PrP 106-126 conserves the pathogenic and physicochemical properties of the Scrapie isoform of the prion protein.
Introduction
Amyloids and their toxicity have been related to the onset and progression of amyloidoses, including neurodegenerative diseases and type II diabetes [1, 2] . In each case, misfolding and aggregation of a native protein are correlated to cell death. Studies from many laboratories have suggested that the molecular agents causing amyloidoses are not the macroscopic, insoluble protein fibrils that have long been taken as the defining feature of these disorders; instead the soluble, transient, prefibrillar protein oligomers have been implicated as the primary causative agents [3] [4] [5] [6] [7] [8] . While the molecular structures of the fibrillar amyloids [9] [10] [11] and the prefibrillar oligomers [8, 12] are being clarified, the mechanism by which either the fibrillar or the prefibrillar species trigger cell death is still unknown. Since the early 2000's there emerged several lines of evidence pointing to a common mechanism for most or all amyloid proteins. Firstly, the cytotoxicity of a range of proteins that are able to aggregate in vitro into fibrils but are not associated with amyloid diseases suggests inherent toxicity of protein aggregates [1, 13] . Secondly, all amyloid fibrils have a common atomic structure [10, 11, 14] and so do the prefibrillar protein oligomers [2, 7, 12] . Thirdly, many amyloid proteins have been found to induce ion leakage through lipid bilayers [15, 16] , thus if acting on cell membranes the effect could lead to loss of membrane potential and cell death. Studies [16] found that unrelated amyloidal proteins all permeabilized lipid bilayers to a similar degree and all ion-conductivities occurred without any evidence of discreet channel or pore or ion selectivity. This is consistent with independent reports of unregulated membrane permeabilization induced by many known amyloid proteins, although some of them were assumed to form pores based on pore-like AFM images (see review [2] ).
There have been many studies on membrane binding by amyloid peptides and subsequent structural transformations of the peptides (see reviews [2, 17, 18] ). In general, at very low concentrations, for example in biological fluids, the peptides remain monomeric and unstructured. However, amyloid peptides being amphipathic have relatively high affinities for membrane binding. Upon binding to lipid bilayers, the peptides transform to helical and/or β-sheet structures, depending on the peptide to lipid ratios. There are at least two different hypotheses about how amyloid peptides might affect the membrane permeability to ions. One hypothesis is that the membrane-bound amyloids include pore-like protofibrils [19] [20] [21] [22] [23] that allow ions to pass through (see review [2] ). Another hypothesis is that amyloids cause membrane permeability by perturbing the membrane structure, but not by pore formation [24] [25] [26] [27] [28] [29] [30] . However, most experiments were not able to show how amyloid peptides perturbed membrane structures.
Because this is such a difficult problem, we believe that it is useful to know the time sequence of peptide-membrane interactions as a function of peptide to lipid ratio. This will help clarify the molecular process of the interactions. Such kinetic studies are possible only if the time constant of interaction is compatible with the method of measurement. We found such a case in PrP 106-126.
Many notable neurodegenerative diseases in mammals such as Creutzfeldt-Jakob disease, Kuru and bovine spongiform encephalopathy are associated with an abnormal Scrapie isoform of prion protein (PrP Sc ) [31] . PrP 106-126, a 21-residue peptide derived from the unstructured N-terminal of the full-length prion protein, has been found to form amyloid fibrils [7, 32, 33] and conserve the pathogenic and physicochemical properties of PrP Sc [34] [35] [36] , consequently it has been used as a model peptide to study prion-related diseases. Like many other amyloid peptides, PrP 106-126 has been shown to interact with model membranes of various compositions [37] , induce liposome aggregation [37, 38] , and form ion channels or pores in planner lipid bilayers [39, 40] . On the other hand, it was also found to increase the membrane conductance without any evidence of discrete channel or pore formation or ion selectivity [16] . Miura et al. [41] studied the circular dichroism (CD) spectra of PrP 106-126 as a function of peptide-to-lipid ratio and the role of negatively charged lipids, particularly that of gangliosides in its β-sheet formation. Their results are invaluable for our design of kinetic experiments.
Experiment and method

Materials
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-snglycero-3-phospho-(1′-rac-glycerol) (DOPG), and 1,2-dioleoyl-snglycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Rh-DOPE) were purchased from Avanti Polar Lipids (Alabaster, AL). PrP 106-126 with blocked termini (acetyl-KTNMKHMAGAAAAGAVVGGLGamide) was synthesized by GenScript (Piscataway, NJ) and PrP 106-126 with free termini (KTNMKHMAGAAAAGAVVGGLG) was purchased from AnaSpec (Fremont, CA), both are of N 95% purity. Dipotassium hydrogen phosphate (K 2 HPO 4 ) and potassium dihydrogen phosphate (KH 2 PO 4 ) were from Fisher Scientific (Waltham MA). All materials were used as delivered.
Kinetic experiment with SUV
To form small unilamellar vesicles (SUVs) of 7:3 DOPC and DOPG, lipids were first dissolved in chloroform to a concentration of 25 mg/ml. The solvent first evaporated under a stream of nitrogen and was further removed in a vacuum desiccator for at least 60 min. Multilamellar vesicles (MLVs) were prepared by swelling the resulted lipid film in aqueous solution to a final concentration of 10 mg/ml, then vortexing periodically for 5 min. A cup-horn sonicator was then used to sonicate the MLVs for 20 min to produces small unilamellar vesicles (SUVs). Finally, SUVs were passed through track-etched polycarbonate membranes with 30-nm pores at least 19 times using a mini-extruder apparatus (Avanti Polar Lipids, Alabaster, AL, USA). All SUVs were used on the same day of preparation.
PrP peptides at a final concentration of 100 μM were mixed with a SUV suspension in phosphate buffer (pH 6.0) at a chosen peptide-tolipid ratio for CD measurement. CD spectra were measured in a Jasco (Tokyo, Japan) J-810 Spectropolarimeter. The spectra were scanned at room temperature in a sealed, quartz optical cell with a 1 mm path length, from wavelength 185 to 250 nm at a scan rate of~4 min/scan. The first scan was measured right after the mixing and subsequently the sample was scanned at the time indicated in the figures below.
Kinetic experiment with aspirated GUV
The method of micropipette aspiration of giant unilamellar vesicles (GUVs) was a modification of the original method of Kwok and Evans [42] as described in Sun et al. [43, 44] . A micropipette was connected to a water-filled U tube manometer and a negative pressure (~100 Pa producing a membrane tension~0.4 mN/m) in the pipette was produced by adjusting the height of the water level reference to the atmosphere pressure [43] . An aspirated GUV consisted of a spherical part and a cylindrical part (a protrusion into the micropipette), where L p the length of the protrusion, R p the radius of the micropipette, and R v the radius of the spherical part were carefully measured. Then it was straightforward to show ΔA = 2πR p ΔL p + 8πR v ΔR v , and ΔV = πR p 2 ΔL p + 4πR v 2 ΔR v [42] . As long as the osmolality balance between the inside and outside of the GUV was maintained, there should be no change of the GUV volume (the effect of the pressure change by suction was so small that its contribution to the chemical potential change was~10 −3 that of osmolality).
Under the condition ΔV = 0, ΔA was directly proportional to
The fractional area change ΔA/A was calculated from the change of the protrusion length ΔL p . The osmolality of every solution used in the GUV experiment was measured by a dew-point Wescor osmometer (model 5520) (Logan, UT).
There is an important limitation to the aspirated GUV experiment due to water evaporation. Water evaporation would increase the osmolality of the sample solution relative to that inside the GUV and consequently cause an increase in the protrusion length, creating errors, i.e., a background increase, in the measurement of membrane area change [43] . By humidifying the air surrounding the sample chamber, we could limit the errors of the ΔA/A measurement to a negligible level within the first several minutes, and then the background would more or less increase linearly to less than 1% within 10 min of GUV experiment [43] . Thus we limited our aspirated GUV experiments to within 10 min, and understood that the measured values of ΔA/A might include positive errors up to 1% at the end of 10 min.
Results
PrP peptides
We experimented with PrP 106-126 both with free termini and blocked termini. Both exhibited the same CD spectra and have the same structure transformation kinetics. We found that the GUV response to the free-termini PrP was relatively fast, therefore it was used for the GUV experiment to shorten the time of observation. The blocked PrP peptide has a slower structural transition in SUV experiments. It is more suitable for the SUV kinetic experiments. As shown by Miura et al. [41] , the membrane binding affinity of PrP peptides is enhanced by lowering pH to~6. We performed all of our experiments at pH = 6. We stress that this is only to speed up the kinetics. The results of PrPlipid interactions are not pH-dependent as far as we know.
Macroscopic observation with GUV
GUVs of 7:3 DOPC/PG were produced in 200 mM sucrose solution [43, 45] . For each run of experiment, an aspirated GUV was transferred to a chamber containing PrP peptides in a phosphate buffered (2 mM, pH 6.0) sucrose (~198 mM) solution of osmolality equal to that of the GUV content. Without PrP peptides in the solution, the GUVs showed no changes. With 50 μM blocked termini PrP peptides, we found that the GUV membrane area increased b 2% in 10 min. Free termini PrP peptides have a stronger membrane binding affinity than blocked termini PrP peptides. With free termini PrP peptides, we observed a membrane area increase ≲ 2% in 10 min for peptide concentrations ≤ 5 μM. We performed the GUV experiments with free termini PrP peptide at 10 μM. Fig. 1 shows representative GUV responses to 10 μM free termini PrP peptide. In general, the membrane area of the GUV initially increased 3-4% within 3 min. Then the protrusion length began to decrease and extramembranous aggregates appeared. The aggregates were most clearly seen when they appeared near the equator of the GUV where the microscope's focal plane was set. In about 30% of the runs, the GUV membrane area increased and decreased twice within 10 min. This phenomenon has been previously observed in GUVs interacting with penetratin [45] .
Kinetic experiment with SUV
PrP peptide was mixed with SUV (7:3 DOPC/DOPG) suspensions at different lipid concentrations from 0.35 mg/ml to 8 mg/ml. The background CD spectrum for each sample was measured without the peptide. This background was removed from each reported CD spectrum below. All samples had the same amount of peptide (100 μM) except for lipid at 8 mg/ml which was mixed with 50 μM PrP. First we Fig. 2. (A) CD spectra of PrP 106-126 in three different configurations: α-helix (blue), β-sheet (red), and random coil (green) in a unit expressed in mdeg for the same concentration of 100 μM of peptide. (B) Time series of CD spectra, from bottom to top, for 100 μM PrP peptide in 0.7 mg/ml lipid vesicles (P t /L = 1/9). (C) Time series of CD spectra, from bottom to top, for 100 μM PrP peptide in 4 mg/ml lipid vesicles (P t /L = 1/50). In both (B) and (C), the data are shown by the symbols indicated by the time of measurement, and the red dots are the fit to a linear combination of three spectra shown in (A). All measurements were made with the same amount of peptide, so all CD spectra are normalized relatively to each other.
established the CD spectra of PrP peptide in three configurations ( Fig. 2A) . In a pure phosphate buffer, the peptide was in a random coil configuration; in 4 mg/ml SUV of 1:1 DOPC/DOPG suspension the peptide had a CD of the α-helical configuration, closely similar to its CD in tetrafluoroethylene; in 2 mg/ml suspension the peptide evolved to a stable β-sheet configuration after one day ( Fig. 2A) .
Each kinetic experiment started with PrP peptides in the monomeric random-coil state. Lipid vesicles of DOPC/DOPG 7:3 at various total peptide to lipid ratios (P t /L) were mixed with the peptide. The first CD measurement of a sample completed in about 4 min (shown as t = 0 in Figs. 3 and 4) . Subsequently, depending on the rate of change, CD was measured at longer time intervals. As examples, two series of kinetic measurements are shown in Fig. 2B and C. Each CD spectrum was decomposed into the components of random-coil, α-helical and β-sheet states by linear fitting. The kinetic data are presented in Fig. 3 for large P t /L values and in Fig. 4 for small P t /L values. The SUVs in the samples reported in Figs. 3 and 4 did not cause significant light scattering. However samples of any lower P t /L value (higher lipid concentrations) would have significant light scattering that distorts the CD spectra.
Discussion
Amyloid aggregation of proteins in solution has been described as nucleation-dependent polymerization [1, 46] . It has been argued that this is a general property of polypeptides [13, 47] , but at physiological concentrations polymerization is normally prevented from occurring by the energy barrier for nucleation [1] . Here we take the view that the toxicity of the amyloid peptide occurs if the amyloid formation process is mediated by cell membranes, since membrane permeabilization to ions has been repeatedly detected in the presence of amyloidal peptides (see refs cited in [2, 16] ). Indeed, membranes have been implicated as the catalyst that facilities amyloid formation (see review [17, 48, 49] ). For many peptides, such as Aβ [17, 50] , IAPP [18, 29, 51] , PrP [41] , and penetratin [45, 52] it has been known that unstructured peptide monomers in solution transform into α-helices upon binding to membranes. As the bound peptide to lipid ratio, P b /L, increases, peptides were found in β-sheets, presumably in an aggregated form. Is there an energy barrier for the membrane-mediated β-sheet formation? What is the effect of this transformation to the membrane Fig. 3 . Kinetics of PrP peptide conformation changes at high total peptide to lipid ratios (P t /L). The sample conditions were: 100 μM PrP in 0.35 mg/ml lipid (P t /L = 1/4), in 0.7 mg/ml lipid (P t /L = 1/9), and in 1.5 mg/ml lipid (P t /L = 1/19). Data are on the left column (note the initial time scale expansion), and the corresponding simulations on the right, where m is the number of lipid vesicles in simulations (see text or the Supporting information). Each simulation result was the average of five repeated simulations. Green represents the fraction of the peptide in random coils, blue α-helices and red β-sheets. The black dashed lines in simulations are the "starting time" to be compared with the first measurements in the kinetic experiments.
properties? These are important questions, if the amyloid formation in membranes is indeed the cause of toxicity.
We suspect that amyloid formation might affect the membrane properties because we have observed in GUV experiments that amyloid peptides, such as hIAPP [29] and penetratin [45, 52] , formed extramembranous aggregates including lipids that desorbed from the lipid bilayers of the vesicles. The appearance of the extramembranous aggregates was coincidental with the decrease of membrane area, consistent with the membrane losing lipid molecules [29, 45, 52] . These were macroscopic observations. The aggregates caused by amyloid peptides must grow to a micron or larger scale to be seen under microscope. The time constant for forming macroscopic aggregates varies with peptides: relatively short for penetratin [45, 52] , longer for hIAPP [29] . If lipid vesicles were suspended in solution with amyloid peptides, eventually very large aggregates including lipids would appear [29, 53] . The effect of the PrP peptide on GUVs (Fig. 1) is the same as penetratin and hIAPP. First the binding of PrP peptide to a GUV caused a membrane area expansion implying that the peptides inserted into the headgroup region of the bilayer (this was called a wedge effect [54, 55] ). Then the expansion stopped and the area began to decrease indicating that the lipid bilayer was losing peptide or lipid or both. Within the experimental time limit of~10 min (see Experiment and method), sometimes the GUV membrane area would increase and decrease twice. Large extramembranous aggregates including lipid molecules were occasionally visible during the membrane area decrease. If lipid vesicles were suspended in a solution containing PrP 106-126, networks of aggregates, characteristic of amyloid aggregation including lipids [29, 53] , inevitably appeared (Fig. 5). [Note that the time scale for aggregation is much shorter in a GUV experiment (Fig. 1) than in a SUV suspension (Figs. 3, 4, 5) , because the peptide to lipid ratio is many orders of magnitude higher in the former than in the latter [56] .] The GUV experiments offered a large scale observation of the lipid extracting effect. To see if the same effect is extended to the molecular level, we performed kinetic experiments with SUVs where we monitored the peptide conformation transformation and interpreted the data with a simple molecular simulation.
In the kinetic experiment with SUVs, the first CD scan completed~4 min after mixing was always a linear combination of Fig. 4 . Kinetics of PrP peptide conformation changes at low total peptide to lipid ratios (P t /L). The sample conditions were: 100 μM PrP in 2 mg/ml lipid (P t /L = 1/25), and in 4 mg/ml lipid (P t /L = 1/50); 50 μM PrP in 8 mg/ml lipid (P t /L = 1/200). Data are on the left column (note the initial time scale expansion for P t /L = 1/25), and the corresponding simulations on the right, where m is the number of lipid vesicles in simulations (see text or the Supporting information). Each simulation result was the average of five repeated simulations. Green represents the fraction of the peptide in random coils, blue α-helices and red β-sheets. The black dashed lines in simulations are the "starting time" to be compared with the first measurements in the kinetic experiments. random coils and alpha helices, and the helical component increased with increasing lipid concentration. The kinetics of peptide binding to lipid vesicles was too fast to be detected by CD measurement. (We measured the spectral intensity change at one wavelength of 201.5 nm immediately after mixing and found that the change was completed within 20 s-see Supporting information Fig. S1 .) As time went on, both the α-helical and random coil components decreased while the β-sheet component increased (Figs. 3 and 4) . We used a set of simple rules to numerically simulate these data (see details in the Supporting information). A simulation starts with 100 peptide monomers and m number of vesicles, each of which has 12 lipid-sites for peptide binding. Each Monte Carlo (MC) step picks a peptide: (i) If the peptide is random-coil, it probabilistically binds to an empty lipid-site and transforms to a helix, otherwise remains a random-coil. If the peptide finds a binding site in a vesicle, and if the number of helices in the vesicle is less than a critical P b /L* value of 1/4, the helices in this vesicle stay. But if the number of helices in the vesicle reaches a P b /L value of 1/4, all of the peptides in that vesicle transform to a β-aggregate and simultaneously the vesicle loses 4 lipid-sites as part of the aggregate. After the desorption of the peptide-lipid aggregate, the vesicle becomes smaller and continues to bind peptides. (ii) If the MC step picks a helical peptide, the helix is allowed to transfer to another empty lipid-site, presumably through vesicle-vesicle collision. Again the rule of transformation to a β-aggregate applies after the transfer. (iii) If the MC step picks a β-sheet peptide, nothing changes. The actual program is given in the Supporting information. The simulation results are compared with the kinetic data in Figs. 3 and 4 .
By making the MC steps corresponding to the experimental time, we note that in the experiment all peptides react with membranes simultaneously, while a simulation takes only one peptide molecule in each step. Therefore the "time" has been stretched out in simulations. Since the binding of peptides to vesicles was too fast to be measured by CD, in each simulation (Figs. 3 and 4) , we drew a "starting time" (the dashed lines in Figs. 3 and 4) corresponding to the time of the first measurement. We also note that in the experiment there is a time delay in converting α-helices to β-aggregates-note that the β-sheet component was zero at the first CD measurement in each case which was completed in~4 min while the initial peptide binding was completed within 20 s. This suggests that there might be a nucleation barrier for membranebound helical peptides converting to β-sheet aggregates. Thus our "starting time" in simulation was the time the α-helix component reached the maximum, because in the experiment this was when β-sheets began to form. This "starting time" took more MC steps as the ratio P b /L decreased, because more peptides were initially bound to the vesicles.
Once we take into account the MC "time," we see an excellent qualitative agreement between the kinetic data and the simulations following the simple rules described above for a wide range of peptide to lipid ratios. Thus we are able to draw the following conclusions: (1) The peptides must bind to a membrane and turns into an α-helix before converting into a β-sheet. It is very well known that the amyloid peptides appear as helices at low P b /L, but as β-sheets at high P b /L. However, only the kinetic experiments show that β-sheets come from helices, not directly from random coils. (2) The membrane bound helices must reach a critical value of P b /L* before converting into β-sheets. In the P t /L = 1/200 case, all peptides remained in the α-helical state; there were no β-sheets, because P b /L was below the critical value. (3) The GUV experiments showed large PrP peptide aggregates desorbed from the lipid bilayer, same as in previous GUV experiments with other amyloid peptides [29, 45, 52 ,57]-we called this a lipid extracting effect because lipid molecules were part of the extramembranous aggregates. Accordingly in simulations we assumed that the lipid vesicles lost lipid molecules whenever β-sheet aggregates were formed. (4) After losing lipid molecules to extramembranous aggregates, the vesicle membrane continued to bind peptides as demonstrated in the GUV experiment (Fig. 1) . We wish to draw attention to the kinetic results, particularly obvious in Fig. 3 , that the amount of final β-sheet component was much higher than the maximum α-helical component from the initial binding, which completed withiñ 20 s. Thus a substantial amount of the final β-sheet component had to come from the peptides subsequently bound to lipid vesicles after the peptides from the initial binding had converted to β-aggregates and desorbed from the lipid vesicles. In the high P t /L cases (e.g., P t /L = 1/4 and P t /L = 1/9), the lipid molecules were eventually used up-all became part of the β-sheet aggregates, and the excessive peptides that had not bound to vesicles remained in the random coil state.
Thus we conclude that the main perturbation effect the amyloid peptides exert on membranes is extracting lipid molecules from the membrane via the process of membrane-mediated amyloid formation. Otherwise the process left the GUV intact. This kinetic study offers a model of peptide-membrane interaction for the lipid extracting effect. Can this effect cause the membrane permeable to ions?
Lipid extraction and ion leakage
Ion permeation through a membrane has been extensively studied by molecular simulations [58] [59] [60] [61] [62] . The consensual results can be summarized as follows: (i) ion permeation is an activated process; spontaneous ion permeation is rare [61, 62] ; (ii) ions enter the bilayer with a trail of water molecules called water fingers [58] (the potential energy for an isolated ion in membrane is too high). The water finger is lined by lipid headgroups. This results in a major rearrangement of neighboring lipids, commonly called water pore defects [58] [59] [60] [61] [62] ; (iii) simulations by displacing a pair of chain-to-chain lipid molecules from a bilayer create a water pore defect, allowing ion permeation [60] ; and (iv) the transient water pores created by activated ion permeation or by the lipid molecule displacement have radii less than 1 nm [59] , and life time of 10-100 ns [59, 60] . Thus it is reasonable to expect that lipid extraction from a membrane can lead to ion permeability.
Currently there are several different suggestions about how amyloid formation might cause ion permeabilization in membranes. It has been suggested that amyloid formation includes pore-like structures within the membrane [19] [20] [21] [22] [23] (see review [2] ); amyloid formation creates defects in membrane structures [26, 27, 30] ; or the process of amyloid formation extracts lipid molecules and damages the membrane [24, 53] . Here we showed that the lipid extracting effect by amyloid peptides previously observed at the macroscopic scale in GUVs is consistent at the molecular scale by kinetic experiments with SUVs. We showed that membrane-mediated amyloid formation is a cooperative transition by membrane-bound α-helices to β-aggregates which occurs only when P b /L exceeds a critical value. The β-aggregates desorb from the membrane, but otherwise leave the GUV intact. The desorbed aggregates include lipid molecules, implying lipid extraction from the membrane. Therefore we propose that the process of lipid extraction creates transient water defects in the membrane resulting in ion permeability.
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